14 The nonrandomized use of WLI (n=44) showed a trend toward improved 3-year progression-free survival (PFS) of 37% vs 21% in this population, but this was not statistically significant ( P =0.18). 14 Nevertheless, WLI is generally well tolerated and is often utilized for those patients who can achieve second remission.
1
—
—